Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2117996 | 0.91 | ZDHHC7 (0.44) | CA2CA1ZDHHC7GPR84FFAR1 | |
| SCHEMBL21694542 | 0.89 | CA2 (0.42) | CA2CA1ZDHHC7TSHRCYP3A4 | |
| SCHEMBL27653256 | 0.86 | NAAA (0.46) | CA2CA1ZDHHC7TSHRMAPT | |
| SCHEMBL28286148 | 0.85 | ZDHHC7 (0.37) | CA2CA1ZDHHC7TSHRCYP3A4 | |
| SCHEMBL13269368 | 0.85 | ZDHHC7 (0.47) | CA2CA1ZDHHC7GPR84FFAR1 | |
| SCHEMBL28919681 | 0.84 | NAAA (0.47) | ZDHHC7TSHRMAPT | |
| SCHEMBL28139049 | 0.83 | CA2 (0.40) | CA2CA1TSHRCYP3A4ATM | |
| SCHEMBL7070785 | 0.83 | ZDHHC7 (0.50) | CA2ZDHHC7GPR84FFAR1CPB2 | |
| SCHEMBL19690704 | 0.83 | ZDHHC7 (0.50) | CA2ZDHHC7GPR84FFAR1CPB2 | |
| SCHEMBL234311 | 0.82 | CA2 (0.47) | CA2CA1ZDHHC7TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10946101-B2 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | VYNE THERAPEUTICS INC. (US) | 2021-03-16 | — | — | US | claimed |
| US-20210015927-A1 | SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES | SWK FUNDING LLC | 2021-01-21 | — | — | US | claimed |
| US-20190134204-A1 | SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES | SWK FUNDING LLC | 2019-05-09 | — | — | US | claimed |
| US-10137200-B2 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | FOAMIX PHARMACEUTICALS LTD. (IL) | 2018-11-27 | — | — | US | claimed |
| US-20180193469-A1 | SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES | FOAMIX PHARMACEUTICALS LTD. (IL) | 2018-07-12 | — | — | US | claimed |
| US-8945516-B2 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | FOAMIX PHARMACEUTICALS LTD. (IL) | 2015-02-03 | — | — | US | claimed |
| US-20070154439-A1 | Cosmetic composition for use around the eyes | DORF PAULA | 2007-07-05 | — | — | US | claimed |
| CN-115531250-B | Sustained-release cosmetic composition with grid structure and lasting dynamic oil control balance | 上海永熙信息科技有限公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-116602891-A | Breathable oil-water balanced skin-nourishing plant soft film cosmetic composition before makeup | 上海永熙信息科技有限公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-115531250-A | Dynamic oil control balance lasting slow-release cosmetic composition with grid structure | 上海永熙信息科技有限公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-114980895-A | Metered dose for demodex and related disorders | 阿祖拉眼科有限公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-114980957-A | Metered dose for intraocular or periocular disorders | 阿祖拉眼科有限公司 | 2022-08-30 | — | — | CN | disclosed |
| US-10653610-B2 | Essentially anhydrous hair-treatment compositions comprising a bis-urea derivative and silica aerogel | L'OREAL (FR) | 2020-05-19 | — | — | US | disclosed |
| CN-104168873-A | Colour changing composition | OREAL | 2014-11-26 | — | — | CN | disclosed |
| CN-104168870-A | Color changing composition in gel form | OREAL | 2014-11-26 | — | — | CN | disclosed |
| CN-104168874-A | Color-changing composition with polyol | OREAL | 2014-11-26 | — | — | CN | disclosed |
| CN-104168959-A | Color-changing composition with UV filter | OREAL | 2014-11-26 | — | — | CN | disclosed |
| CN-104168871-A | Changing-color composition in foam form | OREAL | 2014-11-26 | — | — | CN | disclosed |
| WO-2011061672-A1 | MIXTURE OF HYDROCARBON SOLVENTS | L'OREAL (FR) | 2011-05-26 | — | — | WO | disclosed |
| CN-101702880-A | Highly stable electrolyzed water with reduced NMR half-value width | AKUATECH S R L | 2010-05-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10653610-B2 | Essentially anhydrous hair-treatment compositions comprising a bis-urea derivative and silica aerogel | FHIT, SUCLG1, SHH | CA2 2379/4885CA1 1581/4885ZDHHC7 2786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.